Fidelity’s FMR Reports Major Passive Position in AGL Stock

Rhea-AI Filing Summary

FMR LLC (Fidelity) and Chair & CEO Abigail P. Johnson filed a Schedule 13G reporting a passive 9.4 % stake in agilon health, Inc. (AGL) as of 30 Jun 2025. The group beneficially owns 38,760,723 common shares, with FMR holding sole voting power over 38,742,056 shares and sole dispositive power over the full position; no shared voting or dispositive rights were disclosed. The filing was made under Rule 13d-1(b) for a parent holding company/control person, indicating the shares were acquired in the ordinary course of business and not to influence control of the issuer. No other individual investor within the Fidelity complex owns more than 5 % of AGL. The declaration, signed 5 Aug 2025 by attorney-in-fact Richard Bourgelas, certifies passive intent. While the disclosure does not signal corporate action, it materially raises AGL’s institutional ownership base and may enhance liquidity and market visibility.

Positive

• FMR LLC discloses a 9.4 % passive stake (38.8 m shares), adding a respected long-term institutional holder to AGL’s register.

Negative

• None.

Insights

Portfolio Manager

TL;DR – Fidelity now owns 9.4 % of AGL, boosting institutional backing but with passive intent.

FMR LLC’s 38.8 m-share position places it among agilon health’s largest shareholders. Sole voting and dispositive authority suggest internal alignment, yet the 13G designation and certification of non-control intentions mean no activist agenda is implied. For existing investors, the presence of a sophisticated long-term holder like Fidelity can tighten the float, potentially reduce volatility and attract additional coverage. However, the stake alone does not change agilon’s fundamentals, so the market impact should be viewed as supportive rather than transformative.

Corporate Governance Specialist

TL;DR – Large passive stake, no governance pressure expected.

Because FMR filed on Schedule 13G instead of 13D, it affirms a passive posture, signalling it will not seek board seats or policy changes. Abigail P. Johnson’s mirrored ownership but zero voting power underscores internal delegation of authority within Fidelity’s structure. Investors should not anticipate governance activism; nonetheless, the 9.4 % block gives Fidelity meaningful influence should it ever switch to an active stance. Current risk of control contest remains minimal.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

AGILON HEALTH INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

00857U107

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 00857U107

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 38,742,056.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 38,760,723.28
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

38,760,723.28

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP No. 00857U107

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 38,760,723.28
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

38,760,723.28

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: AGILON HEALTH INC
(b)	Address of issuer's principal executive offices: 6210 E HWY 290,Suite 450,Austin,TX,US,78723
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 00857U107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 38760723.28
(b)	Percent of class: 9.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 38760723.28
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of AGILON HEALTH INC. No one other person's interest in the COMMON STOCK of AGILON HEALTH INC is more than five percent of the total outstanding COMMON STOCK.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	08/05/2025

Abigail P. Johnson

Signature:	Richard Bourgelas
Name/Title:	Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson*
Date:	08/05/2025

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

How many agilon health (AGL) shares does FMR LLC own?

FMR LLC reports beneficial ownership of 38,760,723 common shares.

What percentage of AGL’s outstanding shares does this represent?

The position equals 9.4 % of the company’s common stock.

Does FMR LLC have voting control over the shares?

It holds sole voting power over 38,742,056 shares and no shared voting rights.

Is Fidelity’s position active or passive?

The Schedule 13G was filed under Rule 13d-1(b), indicating a passive ownership stance.

Who signed the filing on behalf of FMR LLC and Abigail P. Johnson?

Attorney-in-fact Richard Bourgelas signed under a power of attorney dated 23 May 2023.